Published in Drug Metab Dispos on October 29, 1976
Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate. Drug Metab Dispos (1976) 2.23
The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metab Dispos (1982) 1.79
Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol (1975) 1.46
Common genetic and environmental contributions to post-traumatic stress disorder and alcohol dependence in young women. Psychol Med (2010) 1.39
Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activities. J Med Chem (1980) 1.23
Electron-capture GLC determination of timolol in human plasma and urine. J Pharm Sci (1975) 1.17
Identification of the biologically active form of sulindac. J Pharmacol Exp Ther (1977) 1.14
Effect of experimental diabetes on elimination kinetics of diflunisal in rats. Drug Metab Dispos (1989) 1.14
Physiological disposition and metabolism of timolol in man and laboratory animals. Drug Metab Dispos (1976) 1.14
Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. Drug Metab Dispos (1980) 1.11
The effects of probenecid upon the individual components of indomethacin elimination. J Pharmacol Exp Ther (1977) 0.97
Cannabis or alcohol first? Differences by ethnicity and in risk for rapid progression to cannabis-related problems in women. Psychol Med (2012) 0.93
Effects of route of administration on the production of gastric hemorrhage in the rat by aspirin and sodium salicylate. Am J Dig Dis (1971) 0.90
Sperm-oviduct interaction: induction of capacitation and preferential binding of uncapacitated spermatozoa to oviductal epithelial cells in porcine species. Biol Reprod (1999) 0.89
Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine. J Chromatogr (1985) 0.88
Aspirin: intestinal damage in rats. Science (1970) 0.87
Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism. J Pharmacol Exp Ther (1985) 0.84
Comparative disposition of sulindac and metabolites in five species. Biochem Pharmacol (1978) 0.82
Adenosine analogues with specificity for A2 receptors bind to mouse spermatozoa and stimulate adenylate cyclase activity in uncapacitated suspensions. J Reprod Fertil (1993) 0.81
Route-dependent nonlinear pharmacokinetics of a novel HIV protease inhibitor: involvement of enzyme inactivation. Drug Metab Dispos (2000) 0.79
Inhibition of histamine synthesis in vitro and in vivo by S-alpha-fluoromethylhistidine. Biochem Pharmacol (1984) 0.79
Interspecies differences in stereoselective protein binding and clearance of MK-571. Drug Metab Dispos (1990) 0.79
Effect of salt concentration and unfrozen water fraction on the viability of slowly frozen ram spermatozoa. Cryobiology (1988) 0.78
Uptake of the beta-adrenergic blocking agents propranolol and timolol by rodent brain: relationship to central pharmacological actions. J Cardiovasc Pharmacol (1980) 0.78
Renal handling of alendronate in rats. An uncharacterized renal transport system. Drug Metab Dispos (1992) 0.78
Analgesic activity of diflunisal [MK-647; 5-(2,4-difluorophenyl)salicylic acid] in rats with hyperalgesia induced by Freund's adjuvant. J Pharmacol Exp Ther (1979) 0.78
A sensitive analytical method for the determination of a novel lipoxygenase inhibitor, 4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one, in plasma using reductive electrochemical detection. J Pharm Sci (1987) 0.77
Absorption, metabolism, and excretion of thiabendazole in man and laboratory animals. Toxicol Appl Pharmacol (1966) 0.76
Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits. Teratology (1984) 0.76
The effect of vasoactive agents on stress-induced gastric hemorrhage in the rat. Digestion (1971) 0.76
An electron-capture gas chromatographic procedure for the estimation of oxalic acid in urine. Anal Biochem (1979) 0.76
In vitro maintenance of boar sperm viability by a soluble fraction obtained from oviductal apical plasma membrane preparations. Reproduction (2003) 0.76
Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist. Drug Metab Dispos (1990) 0.75
The physiological disposition of aerosolized 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate (L-648,051) in rats. Drug Metab Dispos (1989) 0.75
Gastrointestinal absorption and secretion of thiabendazole in ruminants. Am J Vet Res (1966) 0.75
Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs. Drug Metab Dispos (1989) 0.75
4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures. Thromb Diath Haemorrh (1969) 0.75
Bioanalysis and disposition of alpha-fluoromethylhistidine, a new histidine decarboxylase inhibitor. J Pharm Sci (1985) 0.75
Uptake of alendronate by bone tissue in hypocalcemic and hypercalcemic rats. Drug Metab Dispos (1993) 0.75
Physiological disposition and metabolism of 2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride. Drug Metab Dispos (1980) 0.75
Mechanism of action of synthetic fibrinolytic compounds. Thromb Diath Haemorrh (1970) 0.75
The bioavailability and nonlinear pharmacokinetics of MK-679 in humans. Biopharm Drug Dispos (1994) 0.75
Sensitive gas-liquid chromatographic procedure for urinary N tau-methylimidazole acetic acid, an index of histamine turnover. J Chromatogr (1984) 0.75
Perioperative management of neonatal aortic isthmic coarctation. Anaesth Intensive Care (1985) 0.75
Timolol metabolism in man and laboratory anamals. Drug Metab Dispos (1980) 0.75
Absorption, metabolism and elimination of thiabendazole in farm animals and a method for its estimation in biological materials. J Pharmacol Exp Ther (1965) 0.75